Creatine supplementation during pregnancy: Summary of experimental studies suggesting a treatment to improve fetal and neonatal morbidity and reduce mortality in high-risk human pregnancy

BMC Pregnancy and Childbirth

Volumn 14, Issue 1, 2014, Pages

  Dickinson, Hayley ^a   Ellery, Stacey ^a   Ireland, Zoe ^b   LaRosa, Domenic ^a   Snow, Rodney ^c   Walker, David W ^a,d  

^a MONASH UNIVERSITY   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c DEAKIN UNIVERSITY   (Australia)

^d MONASH MEDICAL CENTRE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE RECEPTOR; CREATINE; CREATINE KINASE; CREATINE PHOSPHATE; GLUTAMIC ACID; GUANIDINOACETATE METHYLTRANSFERASE; GUANIDINOACETIC ACID;

ACID BASE BALANCE; ACUTE KIDNEY FAILURE; ANTIOXIDANT ACTIVITY; APNEA; ARTIFICIAL MILK; BIRTH; BODY COMPOSITION; BRAIN BLOOD FLOW; BRAIN DAMAGE; BRAIN DEVELOPMENT; BRAIN HEMORRHAGE; BREAST MILK; CELL LOSS; CEREBRAL PALSY; COGNITION; COGNITIVE DEFECT; DIET SUPPLEMENTATION; ENERGY METABOLISM; EPILEPSY; ERYTHROCYTE; EXTRAPYRAMIDAL SYMPTOM; FETUS GROWTH; FETUS HYPOXIA; FETUS MORTALITY; GLUCOSE TOLERANCE; HIGH RISK PREGNANCY; HUMAN; INTELLECTUAL IMPAIRMENT; INTESTINE ABSORPTION; KIDNEY FUNCTION; LIPID MEMBRANE; MATERNAL NUTRITION; METABOLIC SYNDROME X; MIDDLE CEREBRAL ARTERY OCCLUSION; MOTOR DYSFUNCTION; MUSCLE FUNCTION; MUSCLE INJURY; NEUROPROTECTION; NEWBORN MORBIDITY; NEWBORN MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; NUTRITIONAL REQUIREMENT; OSTEOBLAST; OSTEOPENIA; OXIDATIVE STRESS; PERINATAL MORBIDITY; PHYSICAL DISABILITY; PLACENTAL TRANSFER; PREMATURE LABOR; PREMATURITY; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; RESPIRATORY FAILURE; REVIEW; RISK REDUCTION; SARCOPENIA; SEIZURE; SYNAPSE VESICLE; WATER TRANSPORT; FEMALE; FETAL HYPOXIA; HYPOXIA-ISCHEMIA, BRAIN; METABOLISM; MORTALITY; NEWBORN; PREGNANCY; THIRD TRIMESTER PREGNANCY;

CREATINE; DIETARY SUPPLEMENTS; FEMALE; FETAL HYPOXIA; HUMANS; HYPOXIA-ISCHEMIA, BRAIN; INFANT, NEWBORN; PREGNANCY; PREGNANCY TRIMESTER, THIRD; PREGNANCY, HIGH-RISK;

EID: 84899982280     PISSN: None     EISSN: 14712393     Source Type: Journal    
DOI: 10.1186/1471-2393-14-150     Document Type: Review

References (129)

1. Slattery MM, Morrison JJ. Preterm delivery. Lancet 2002, 360(9344):1489-1497. 10.1016/S0140-6736(02)11476-0, 12433531.
2. Graham EM, Ruis KA, Hartman AL, Northington FJ, Fox HE. A systematic review of the role of intrapartum hypoxia-ischemia in the causation of neonatal encephalopathy. Am J Obstet Gynecol 2008, 199(6):587-595. 10.1016/j.ajog.2008.06.094, 19084096.
3. MacLennan A. A template for defining a causal relation between acute intrapartum events and cerebral palsy: international consensus statement. BMJ 1999, 319(7216):1054-1059. 10.1136/bmj.319.7216.1054, 1116849, 10521205.
4. Roberts D, Dalziel S. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev 2006, 19(3):CD004454.
5. Doyle LW, Crowther CA, Middleton P, Marret S, Rouse D. Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus. Cochrane Database Syst Rev 2009, 21(1):CD004661.
6. Kaandorp JJ, van Bel F, Veen S, Derks JB, Groenendaal F, Rijken M, Roze E, Venema MM, Rademaker CM, Bos AF, Benders MJ. Long-term neuroprotective effects of allopurinol after moderate perinatal asphyxia: follow-up of two randomised controlled trials. Arch Dis Child Fetal Neonatal Ed 2012, 97(3):F162-F166. 10.1136/archdischild-2011-300356, 22102633.
7. Kane A, Hansell J, Herrera E, Allison B, Niu Y, Brain K, Kaandorp J, Derks J, Giussani D. Xanthine oxidase and the fetal cardiovascular defence to hypoxia in late gestation ovine pregnancy. J Physiol 2013, 592(Pt 3):475-489.
8. Lawn J, Shibuya K, Stein C. No cry at birth: global estimates of intrapartum stillbirths and intrapartum-related neonatal deaths. Bull World Health Organ 2005, 83(6):409-417. 2626256, 15976891.
9. Lawn JE, Manandhar A, Haws RA, Darmstadt GL. Reducing one million child deaths from birth asphyxia-a survey of health systems gaps and priorities. Health Res Pol Syst 2007, 5:4.
10. du Plessis AJ, Volpe JJ. Perinatal brain injury in the preterm and term newborn. Curr Opin Neurol 2002, 15(2):151-157. 10.1097/00019052-200204000-00005, 11923628.
11. Gluckman PD, Wyatt JS, Azzopardi D, Ballard R, Edwards AD, Ferriero DM, Polin RA, Robertson CM, Thoresen M, Whitelaw A, Gunn AJ. Selective head cooling with mild systemic hypothermia after neonatal encephalopathy: multicentre randomised trial. Lancet 2005, 365(9460):663-670. 10.1016/S0140-6736(05)17946-X, 15721471.
12. Jacobs SE, Hunt R, Tarnow-Mordi WO, Inder TE, Davis PG. Cooling for newborns with hypoxic ischaemic encephalopathy (Review). Evid Based Child Health 2010, 5:474-531.
13. Shah PS, Ohlsson A, Perlman M. Hypothermia to treat neonatal hypoxic ischemic encephalopathy: systematic review. Arch Pediatr Adolesc Med 2007, 161(10):951-958. 10.1001/archpedi.161.10.951, 17909138.
14. Edwards AD, Brocklehurst P, Gunn AJ, Halliday H, Juszczak E, Levene M, Strohm B, Thoresen M, Whitelaw A, Azzopardi D. Neurological outcomes at 18 months of age after moderate hypothermia for perinatal hypoxic ischaemic encephalopathy: synthesis and meta-analysis of trial data. BMJ 2010, 340:c363. 10.1136/bmj.c363, 2819259, 20144981.
15. Harris RC, Soderlund K, Hultman E. Elevation of creatine in resting and exercised muscle of normal subjects by creatine supplementation. Clin Sci 1992, 83(3):367-374.
16. Dechent P, Pouwels PJ, Wilken B, Hanefeld F, Frahm J. Increase of total creatine in human brain after oral supplementation of creatine-monohydrate. Am J Physiol 1999, 277(3 Pt 2):R698-R704.
17. Beal MF. Neuroprotective effects of creatine. Amino Acids 2011, 40(5):1305-1313. 10.1007/s00726-011-0851-0, 21448659.
18. Cannata DJ, Ireland Z, Dickinson H, Snow RJ, Russell AP, West JM, Walker DW. Maternal creatine supplementation from mid-pregnancy protects the diaphragm of the newborn spiny mouse from intrapartum hypoxia-induced damage. Pediatr Res 2010, 68(5):393-398.
19. Ellery SJ, Ireland Z, Kett MM, Snow R, Walker DW, Dickinson H. Creatine pretreatment prevents birth asphyxia-induced injury of the newborn spiny mouse kidney. Pediatr Res 2013, 73(2):201-208. 10.1038/pr.2012.174, 23174701.
20. Ireland Z, Castillo-Melendez M, Dickinson H, Snow R, Walker DW. A maternal diet supplemented with creatine from mid-pregnancy protects the newborn spiny mouse brain from birth hypoxia. Neurosci 2011, 194:372-379.
21. Morris JM, Gopaul NK, Endresen MJ, Knight M, Linton EA, Dhir S, Anggard EE, Redman CW. Circulating markers of oxidative stress are raised in normal pregnancy and pre-eclampsia. Br J Obstet Gynaecol 1998, 105(11):1195-1199. 10.1111/j.1471-0528.1998.tb09974.x, 9853769.
22. Myatt L, Cui X. Oxidative stress in the placenta. Histochem Cell Biol 2004, 122(4):369-382. 10.1007/s00418-004-0677-x, 15248072.
23. Miller SL, Wallace EM, Walker DW. Antioxidant therapies: a potential role in perinatal medicine. Neuroendocrinol 2012, 96(1):13-23.
24. Resnik R. Intrauterine growth restriction. Obstet Gynecol 2002, 99(3):490-496. 10.1016/S0029-7844(01)01780-X, 11864679.
25. Lage S, Andradem F, Prieto JA, Asla I, Rodriguez A, Ruiz N, Echeverria J, Couce ML, Sanjurko P, Aldamiz-Echevarria L. Arginine-guanidinoeacetate-creatine pathway in preterm newborns: creatine biosynthesis in newborns. J Pediatr Endocr Met 2013, 26(1-2):53-60.
26. Hulsermann J, Manz F, Wember T, Schoch G. Die Zufuhr von Kreatin and Kreatinin mit Frauenmilch and Sauglingsmilchpraparaten. Kiln Padiat 1987, 199:292-295.
27. Leuzzi V, Mastrangelo M, Battini R, Cioni G. Inborn errors of creatine metabolism and epilepsy. Epilepsia 2013, 54(2):217-227. 10.1111/epi.12020, 23157605.
28. Mercimek-Mahmutoglu S, Stoeckler-Ipsiroglu S, Adami A, Appleton R, Araujo HC, Duran M, Ensenauer R, Fernandez-Alvarez E, Garcia P, Grolik C, Item CB, Leuzzi V, Marquardt I, Muhl A, Saelke-Kellermann RA, Salomons GS, Schulze A, Surtees R, van der Knaap MS, Vasconcelos R, Verhoeven NM, Vilarinho L, Wilichowski E, Jakobs C. GAMT deficiency: features, treatment, and outcome in an inborn error of creatine synthesis. Neurol 2006, 67(3):480-484.
29. Ezaki S, Suzuki K, Kurishima C, Miura M, Weilin W, Hoshi R, Tanitsu S, Tomita Y, Takayama C, Wada M, Kondo T, Tamura M. Resuscitation of preterm infants with reduced oxygen results in less oxidative stress than resuscitation with 100% oxygen. J Clin Biochem Nutr 2009, 44(1):111-118. 10.3164/jcbn.08-221, 2613494, 19177196.
30. Sola A, Saldeno YP, Favareto V. Clinical practices in neonatal oxygenation: where have we failed? What can we do?. J Perinatol 2008, 28(Suppl 1):S28-S34.
31. Muller N, Gulston G, Cade D, Whitton J, Froese AB, Bryan MH, Bryan AC. Diaphragmatic muscle fatigue in the newborn. J Appl Physiol Respir, Environ Exerc Physiol 1979, 46(4):688-695.
32. Rodriguez MM, Gomez AH, Abitbol CL, Chandar JJ, Duara S, Zilleruelo GE. Histomorphometric analysis of postnatal glomerulogenesis in extremely preterm infants. Pediatr Dev Pathol 2004, 7(1):17-25.
33. Volpe JJ. Brain injury in the premature infant: overview of clinical aspects, neuropathology, and pathogenesis. Semin Pediatr Neurol 1998, 5(3):135-151. 10.1016/S1071-9091(98)80030-2, 9777673.
34. Saigal S, Doyle LW. An overview of mortality and sequelae of preterm birth from infancy to adulthood. Lancet 2008, 371(9608):261-269. 10.1016/S0140-6736(08)60136-1, 18207020.
35. Carducci C, Santagata S, Leuzzi V, Carducci C, Artiola C, Giovanniello T, Battini R, Antonozzi I. Quantitative determination of guanidinoacetate and creatine in dried blood spot by flow injection analysis-electrospray tandem mass spectrometry. Clin Chim Acta 2006, 364(1-2):180-187.
36. Girard N, Fogliarini C, Viola A, Confort-Gouny S, Fur YL, Viout P, Chapon F, Levrier O, Cozzone P. MRS of normal and impaired fetal brain development. Eur J Radiol 2006, 57(2):217-225. 10.1016/j.ejrad.2005.11.021, 16387464.
37. Girard N, Gouny SC, Viola A, Le Fur Y, Viout P, Chaumoitre K, D'Ercole C, Gire C, Figarella-Branger D, Cozzone PJ. Assessment of normal fetal brain maturation in utero by proton magnetic resonance spectroscopy. Magn Reson Med 2006, 56(4):768-775. 10.1002/mrm.21017, 16964617.
38. Kreis R, Hofmann L, Kuhlmann B, Boesch C, Bossi E, Huppi PS. Brain metabolite composition during early human brain development as measured by quantitative in vivo 1H magnetic resonance spectroscopy. Magn Reson Med 2002, 48(6):949-958. 10.1002/mrm.10304, 12465103.
39. He J, Inglese M, Li BS, Babb JS, Grossman RI, Gonen O. Relapsing-remitting multiple sclerosis: metabolic abnormality in nonenhancing lesions and normal-appearing white matter at MR imaging: initial experience. Radiol 2005, 234(1):211-217.
40. Azzopardi D, Wyatt JS, Hamilton PA, Cady EB, Delpy DT, Hope PL, Reynolds EO. Phosphorus metabolites and intracellular pH in the brains of normal and small for gestational age infants investigated by magnetic resonance spectroscopy. Pediatr Res 1989, 25(5):440-444. 10.1203/00006450-198905000-00003, 2717258.
41. Dubowitz DJ, Bluml S, Arcinue E, Dietrich RB. MR of hypoxic encephalopathy in children after near drowning: correlation with quantitative proton MR spectroscopy and clinical outcome. Am J Neuroradiol 1998, 19(9):1617-1627.
42. Wyss M, Schulze A. Health implications of creatine: can oral creatine supplementation protect against neurological and atherosclerotic disease?. Neurosci 2002, 112(2):243-260.
43. Bender A, Koch W, Elstner M, Schombacher Y, Bender J, Moeschl M, Gekeler F, Muller-Myhsok B, Gasser T, Tatsch K, Klopstock T. Creatine supplementation in Parkinson disease: a placebo-controlled randomized pilot trial. Neurol 2006, 67(7):1262-1264.
44. Bender A, Auer DP, Merl T, Reilmann R, Saemann P, Yassouridis A, Bender J, Weindl A, Dose M, Gasser T, Klopstock T. Creatine supplementation lowers brain glutamate levels in Huntington's disease. J Neurol 2005, 252(1):36-41. 10.1007/s00415-005-0595-4, 15672208.
45. Sakellaris G, Kotsiou M, Tamiolaki M, Kalostos G, Tsapaki E, Spanaki M, Spilioti M, Charissis G, Evangeliou A. Prevention of complications related to traumatic brain injury in children and adolescents with creatine administration: an open label randomized pilot study. J Trauma 2006, 61(2):322-329. 10.1097/01.ta.0000230269.46108.d5, 16917445.
46. Sakellaris G, Nasis G, Kotsiou M, Tamiolaki M, Charissis G, Evangeliou A. Prevention of traumatic headache, dizziness and fatigue with creatine administration: a pilot study. Acta Paediatr 2008, 97(1):31-34. 2583396, 18053002.
47. Benton D, Donohoe R. The influence of creatine supplementation on the cognitive functioning of vegetarians and omnivores. Br J Nutr 2011, 105(7):1100-1105. 10.1017/S0007114510004733, 21118604.
48. Rawson ES, Venezia AC. Use of creatine in the elderly and evidence for effects on cognitive function in young and old. Amino Acids 2011, 40(5):1349-1362. 10.1007/s00726-011-0855-9, 21394604.
49. Cook CJ, Crewther BT, Kilduff LP, Drawer S, Gaviglio CM. Skill execution and sleep deprivation: effects of acute caffeine or creatine supplementation - a randomized placebo-controlled trial. J Int Soc Sports Nutr 2011, 8:2. 10.1186/1550-2783-8-2, 3049131, 21324203.
50. Gualano B, Novaes RB, Artioli GG, Freire TO, Coelho DF, Scagliusi FB, Rogeri PS, Roschel H, Ugrinowitsch C, Lancha AH. Effects of creatine supplementation on glucose tolerance and insulin sensitivity in sedentary healthy males undergoing aerobic training. Amino Acids 2008, 34(2):245-250. 10.1007/s00726-007-0508-1, 17396216.
51. Gotshalk LA, Kraemer WJ, Mendonca MA, Vingren JL, Kenny AM, Spiering BA, Hatfield DL, Fragala MS, Volek JS. Creatine supplementation improves muscular performance in older women. Eur J Appl Physiol 2008, 102(2):223-231.
52. Gerber I, Ap Gwynn I, Alini M, Wallimann T. Stimulatory effects of creatine on metabolic activity, differentiation and mineralization of primary osteoblast-like cells in monolayer and micromass cell cultures. Eur Cell Mater 2005, 10:8-22.
53. Bender A, Samtleben W, Elstner M, Klopstock T. Long-term creatine supplementation is safe in aged patients with Parkinson disease. Nutr Res 2008, 28(3):172-178. 10.1016/j.nutres.2008.01.001, 19083405.
54. Bizzarini E, De Angelis L. Is the use of oral creatine supplementation safe?. J Sports Med Phys Fitness 2004, 44(4):411-416.
55. Jager R, Purpura M, Shao A, Inoue T, Kreider RB. Analysis of the efficacy, safety, and regulatory status of novel forms of creatine. Amino Acids 2011, 40(5):1369-1383. 10.1007/s00726-011-0874-6, 3080578, 21424716.
56. Kim HJ, Kim CK, Carpentier A, Poortmans JR. Studies on the safety of creatine supplementation. Amino Acids 2011, 40(5):1409-1418. 10.1007/s00726-011-0878-2, 21399917.
57. Gualano B, Roschel H, Lancha-Jr AH, Brightbill CE, Rawson ES. In sickness and in health: the widespread application of creatine supplementation. Amino Acids 2012, 43(2):519-529. 10.1007/s00726-011-1132-7, 22101980.
58. Bohnhorst B, Geuting T, Peter CS, Dordelmann M, Wilken B, Poets CF. Randomized, controlled trial of oral creatine supplementation (not effective) for apnea of prematurity. Pediatr 2004, 113(4):e303-e307.
59. Pritchard NR, Kalra PA. Renal dysfunction accompanying oral creatine supplements. Lancet 1998, 351(9111):1252-1253. 10.1016/S0140-6736(05)79319-3, 9643752.
60. Gualano B, de Salles PV, Roschel H, Lugaresi R, Dorea E, Artioli GG, Lima FR, da Silva ME, Cunha MR, Seguro AC, Shimizu MH, Otaduy MC, Sapienza MT, da Costa Leite C, Bonfa E, Lancha Junior AH. Creatine supplementation does not impair kidney function in type 2 diabetic patients: a randomized, double-blind, placebo-controlled, clinical trial. Eur J Appl Physiol 2011, 111(5):749-756. 10.1007/s00421-010-1676-3, 20976468.
61. Calvert JW, Zhang JH. Pathophysiology of an hypoxic-ischemic insult during the perinatal period. Neurol Res 2005, 27(3):246-260. 10.1179/016164105X25216, 15845208.
62. Wallimann T, Tokarska-Schlattner M, Schlattner U. The creatine kinase system and pleiotropic effects of creatine. Amino Acids 2011, 40(5):1271-1296. 10.1007/s00726-011-0877-3, 3080659, 21448658.
63. Wallimann T, Wyss M, Brdiczka D, Nicolay K, Eppenberger HM. Intracellular compartmentation, structure and function of creatine kinase isoenzymes in tissues with high and fluctuating energy demands: the 'phosphocreatine circuit' for cellular energy homeostasis. Biochem J 1992, 281(Pt 1):21-40. 1130636, 1731757.
64. Rico-Sanz J. Creatine reduces human muscle PCr and pH decrements and P(i) accumulation during low-intensity exercise. J Appl Physiol (1985) 2000, 88(4):1181-1191.
65. Yquel RJ, Arsac LM, Thiaudiere E, Canioni P, Manier G. Effect of creatine supplementation on phosphocreatine resynthesis, inorganic phosphate accumulation and pH during intermittent maximal exercise. J Sports Sci 2002, 20(5):427-437. 10.1080/026404102317366681, 12043832.
66. Lawler JM, Barnes WS, Wu G, Song W, Demaree S. Direct antioxidant properties of creatine. Biochem Biophys Res Comm 2002, 290(1):47-52. 10.1006/bbrc.2001.6164, 11779131.
67. Bender A, Beckers J, Schneider I, Holter SM, Haack T, Ruthsatz T, Vogt-Weisenhorn DM, Becker L, Genius J, Rujescu D, Irmler M, Mijalski T, Mader M, Quintanilla-Martinez L, Fuchs H, Gailus-Durner V, de Angelis MH, Wurst W, Schmidt J, Klopstock T. Creatine improves health and survival of mice. Neurobiol Aging 2008, 29(9):1404-1411. 10.1016/j.neurobiolaging.2007.03.001, 17416441.
68. Guimaraes-Ferreira L, Pinheiro CH, Gerlinger-Romero F, Vitzel KF, Nachbar RT, Curi R, Nunes MT. Short-term creatine supplementation decreases reactive oxygen species content with no changes in expression and activity of antioxidant enzymes in skeletal muscle. Eur J Appl Physiol 2012, 112(11):3905-3911. 10.1007/s00421-012-2378-9, 22415102.
69. Sestili P, Martinelli C, Colombo E, Barbieri E, Potenza L, Sartini S, Fimognari C. Creatine as an antioxidant. Amino Acids 2011, 40(5):1385-1396. 10.1007/s00726-011-0875-5, 21404063.
70. Carter AJ, Muller RE, Pschorn U, Stransky W. Preincubation with creatine enhances levels of creatine phosphate and prevents anoxic damage in rat hippocampal slices. J Neurochem 1995, 64(6):2691-2699.
71. Berger R, Middelanis J, Vaihinger HM, Mies G, Wilken B, Jensen A. Creatine protects the immature brain from hypoxic-ischemic injury. J Soc Gynecol Investig 2004, 11(1):9-15. 10.1016/j.jsgi.2003.07.002, 14706677.
72. Nagasawa T, Hatayama T, Watanabe Y, Tanaka M, Niisato Y, Kitts DD. Free radical-mediated effects on skeletal muscle protein in rats treated with Fe-nitrilotriacetate. Biochem Biophys Res Comm 1997, 231(1):37-41. 10.1006/bbrc.1996.6034, 9070215.
73. Prass K, Royl G, Lindauer U, Freyer D, Megow D, Dirnagl U, Stockler-Ipsiroglu G, Wallimann T, Priller J. Improved reperfusion and neuroprotection by creatine in a mouse model of stroke. J Cerebr Blood Flow Metabol 2007, 27(3):452-459.
74. Koga Y, Takahashi H, Oikawa D, Tachibana T, Denbow DM, Furuse M. Brain creatine functions to attenuate acute stress responses through GABAnergic system in chicks. Neurosci 2005, 132(1):65-71.
75. Pena-Altamira E, Crochemore C, Virgili M, Contestabile A. Neurochemical correlates of differential neuroprotection by long-term dietary creatine supplementation. Brain Res 2005, 1058(1-2):183-188.
76. Hirst JJ, Kelleher MA, Walker DW, Palliser HK. Neuroactive steroids in pregnancy: key regulatory and protective roles in the foetal brain. J Steroid Biochem Mol Biol 2013, 139:144-153.
77. Naito S, Ueda T. Adenosine triphosphate-dependent uptake of glutamate into protein I-associated synaptic vesicles. J Biol Chem 1983, 258(2):696-699.
78. Xu CJ, Klunk WE, Kanfer JN, Xiong Q, Miller G, Pettegrew JW. Phosphocreatine-dependent glutamate uptake by synaptic vesicles: a comparison with atp-dependent glutamate uptake. J Biol Chem 1996, 271(23):13435-13440. 10.1074/jbc.271.23.13435, 8662761.
79. Brewer GJ, Wallimann TW. Protective effect of the energy precursor creatine against toxicity of glutamate and beta-amyloid in rat hippocampal neurons. J Neurochem 2000, 74(5):1968-1978.
80. Tokarska-Schlattner M, Epand RF, Meiler F, Zandomeneghi G, Neumann D, Widmer HR, Meier BH, Epand RM, Saks V, Wallimann T, Schlattner U. Phosphocreatine interacts with phospholipids, affects membrane properties and exerts membrane-protective effects. PloS One 2012, 7(8):e43178. 10.1371/journal.pone.0043178, 3422282, 22912820.
81. Low JA. Determining the contribution of asphyxia to brain damage in the neonate. J Obstet Gynaecol Res 2004, 30(4):276-286. 10.1111/j.1447-0756.2004.00194.x, 15238103.
82. Perlman JM, Tack ED, Martin T, Shackelford G, Amon E. Acute systemic organ injury in term infants after asphyxia. Am J Dis Child 1989, 143(5):617-620.
83. Ireland Z, Dickinson H, Snow R, Walker DW. Maternal creatine: does it reach the fetus and improve survival after an acute hypoxic episode in the spiny mouse (Acomys cahirinus)?. Am J Obstet Gynecol 2008, 198(4):431 e431-436.
84. Ipsiroglu OS, Stromberger C, Ilas J, Hoger H, Muhl A, Stockler-Ipsiroglu S. Changes of tissue creatine concentrations upon oral supplementation of creatine-monohydrate in various animal species. Life Sci 2001, 69(15):1805-1815. 10.1016/S0024-3205(01)01268-1, 11665842.
85. Dickinson H, Ireland ZJ, Larosa DA, O'Connell BA, Ellery S, Snow R, Walker DW. Maternal dietary creatine supplementation does not alter the capacity for creatine synthesis in the newborn spiny mouse. Reprod Sci 2013, 20(9):1096-1102. 10.1177/1933719113477478, 23427185.
86. Holtzman D, Togliatti A, Khait I, Jensen F. Creatine increases survival and suppresses seizures in the hypoxic immature rat. Pediatr Res 1998, 44(3):410-414. 10.1203/00006450-199809000-00024, 9727722.
87. Ohtsuki S, Tachikawa M, Takanaga H, Shimizu H, Watanabe M, Hosoya K, Terasaki T. The blood-brain barrier creatine transporter is a major pathway for supplying creatine to the brain. J Cerebr Blood Flow Metab 2002, 22(11):1327-1335.
88. Schulze A. Creatine deficiency syndromes. Mol Cell Biochem 2003, 244(1-2):143-150.
89. Zhu S, Li M, Figueroa BE, Liu A, Stavrovskaya IG, Pasinelli P, Beal MF, Brown RH, Kristal BS, Ferrante RJ, Friedlander RM. Prophylactic creatine administration mediates neuroprotection in cerebral ischemia in mice. J Neurosci 2004, 24(26):5909-5912. 10.1523/JNEUROSCI.1278-04.2004, 15229238.
90. Lyoo IK, Kong SW, Sung SM, Hirashima F, Parow A, Hennen J, Cohen BM, Renshaw PF. Multinuclear magnetic resonance spectroscopy of high-energy phosphate metabolites in human brain following oral supplementation of creatine-monohydrate. Psychiatr Res 2003, 123(2):87-100.
91. Pan JW, Takahashi K. Cerebral energetic effects of creatine supplementation in humans. Am J Physiol Regul Integr Comp Physiol 2007, 292(4):R1745-R1750. 3570026, 17185404.
92. Braissant O, Henry H, Villard AM, Speer O, Wallimann T, Bachmann C. Creatine synthesis and transport during rat embryogenesis: spatiotemporal expression of AGAT, GAMT and CT1. BMC Dev Biol 2005, 5:9. 10.1186/1471-213X-5-9, 1175845, 15918910.
93. Braissant O. Creatine and guanidinoacetate transport at blood-brain and blood-cerebrospinal fluid barriers. J Inherit Metab Dis 2012, 35(4):655-664. 10.1007/s10545-011-9433-2, 22252611.
94. Watt KK, Garnham AP, Snow RJ. Skeletal muscle total creatine content and creatine transporter gene expression in vegetarians prior to and following creatine supplementation. Int J Sport Nutr Exerc Metabol 2004, 14(5):517-531.
95. North K, Golding J. A maternal vegetarian diet in pregnancy is associated with hypospadias. The ALSPAC study team. Avon longitudinal study of pregnancy and childhood. BJU Int 2000, 85(1):107-113. 10.1046/j.1464-410x.2000.00436.x, 10619956.
96. Mangels AR. Vegetarian Diets in Pregnancy. Handbook of Nutrition and Pregnancy 2008, 215-231. Humana Press, Lammi-Keefe CJ, Couch SC, Philipson EH.
97. Davis BM, Miller RK, Brent RL, Koszalka TR. Materno-fetal transport of creatine in the rat. Biol Neonate 1978, 33(1-2):43-54.
98. Koszalka TR, Jensh R, Brent RL. Creatine metabolism in the developing rat fetus. Comp Biochem Physiol B, Comp Biochem 1972, 41(1):217-229.
99. Miller RK, Davis BM, Brent RL, Koszalka TR. Creatine transport by rat placentas. Am J Physiol 1977, 233(4):E308-E315.
100. Nash SR, Giros B, Kingsmore SF, Rochelle JM, Suter ST, Gregor P, Seldin MF, Caron MG. Cloning, pharmacological characterization, and genomic localization of the human creatine transporter. Recept Channels 1994, 2(2):165-174.
101. Miller R, Davis BM, Brent RL, Koszalka TR. Transport of creatine in the human placenta. Pharmacologist 1974, 16(2):305.
102. Thomure MF, Gast MJ, Srivastava N, Payne RM. Regulation of creatine kinase isoenzymes in human placenta during early, mid-, and late gestation. J Soc Gynecol Investig 1996, 3(6):322-327. 10.1016/S1071-5576(96)00043-3, 8923416.
103. Payne RM, Friedman DL, Grant JW, Perryman MB, Strauss AW. Creatine kinase isoenzymes are highly regulated during pregnancy in rat uterus and placenta. Am J Physiol 1993, 265(4 Pt 1):E624-E635.
104. Smeitink J, Ruitenbeek W, van Lith T, Sengers R, Trijbels F, Wevers R, Sperl W, de Graaf R. Maturation of mitochondrial and other isoenzymes of creatine kinase in skeletal muscle of preterm born infants. Ann Clin Biochem 1992, 29(Pt 3):302-306.
105. Ingwall JS, Kramer MF, Woodman D, Friedman WF. Maturation of energy metabolism in the lamb: changes in myosin ATPase and creatine kinase activities. Pediatr Res 1981, 15(8):1128-1133.
106. Do Amaral VC, Simoes Mde J, Marcondes RR, Matozinho Cubas JJ, Baracat EC, Soares JM. Histomorphometric analysis of the effects of creatine on rat myometrium. Gynecol Endocrinol 2012, 28(8):587-589. 10.3109/09513590.2011.650748, 22309498.
107. Larcombe-McDouall JB, Harrison N, Wray S. The in vivo relationship between blood flow, contractions, pH and metabolites in the rat uterus. Pflugers Archiv: Eur J Physiol 1998, 435(6):810-817.
108. Ireland Z, Russell AP, Wallimann T, Walker DW, Snow R. Developmental changes in the expression of creatine synthesizing enzymes and creatine transporter in a precocial rodent, the spiny mouse. BMC Dev Biol 2009, 9:39. 10.1186/1471-213X-9-39, 2713216, 19570237.
109. Battini R, Leuzzi V, Carducci C, Tosetti M, Bianchi MC, Item CB, Stockler-Ipsiroglu S, Cioni G. Creatine depletion in a new case with AGAT deficiency: clinical and genetic study in a large pedigree. Mol Genet Metabol 2002, 77(4):326-331.
110. Bianchi MC, Tosetti M, Fornai F, Alessandri MG, Cipriani P, De Vito G, Canapicchi R. Reversible brain creatine deficiency in two sisters with normal blood creatine level. Ann Neurol 2000, 47(4):511-513. 10.1002/1531-8249(200004)47:4<511::AID-ANA15>3.0.CO;2-N, 10762163.
111. Garcia-Delgado M, Peral MJ, Cano M, Calonge ML, Ilundain AA. Creatine transport in brush-border membrane vesicles isolated from rat kidney cortex. J Am Soc Nephrol 2001, 12(9):1819-1825.
112. Gubhaju L, Sutherland MR, Yoder BA, Zulli A, Bertram JF, Black MJ. Is nephrogenesis affected by preterm birth? Studies in a non-human primate model. Am J Physiol Renal Physiol 2009, 297(6):F1668-F1677. 10.1152/ajprenal.00163.2009, 2801336, 19759270.
113. Huang CC, Wang ST, Chang YC, Lin KP, Wu PL. Measurement of the urinary lactate:creatinine ratio for the early identification of newborn infants at risk for hypoxic-ischemic encephalopathy. New Engl J Med 1999, 341(5):328-335. 10.1056/NEJM199907293410504, 10423467.
114. Aggarwal A, Kumar P, Chowdhary G, Majumdar S, Narang A. Evaluation of renal functions in asphyxiated newborns. J Trop Pediatr 2005, 51(5):295-299. 10.1093/tropej/fmi017, 16000344.
115. Bosch X, Poch E, Grau JM. Rhabdomyolysis and acute kidney injury. New Engl J Med 2009, 361(1):62-72. 10.1056/NEJMra0801327, 19571284.
116. Lowe SA, Brown MA, Dekker GA, Gatt S, McLintock CK, McMahon LP, Mangos G, Moore MP, Muller P, Paech M, Walters B. Guidelines for the management of hypertensive disorders of pregnancy 2008. Aust New Zeal J Obstet Gynaecol 2009, 49(3):242-246.
117. Meis PJ, Goldenberg RL, Mercer BM, Iams JD, Moawad AH, Miodovnik M, Menard MK, Caritis SN, Thurnau GR, Bottoms SF, Das A, Roberts JM, McNellis D. The preterm prediction study: risk factors for indicated preterm births. Maternal-Fetal Medicine Units Network of the National Institute of Child Health and Human Development. Am J Obstet Gynecol 1998, 178(3):562-567. 10.1016/S0002-9378(98)70439-9, 9539527.
118. Payne B, Magee LA, von Dadelszen P. Assessment, surveillance and prognosis in pre-eclampsia. Best Pract Res Clin Obstet Gynaecol 2011, 25(4):449-462. 10.1016/j.bpobgyn.2011.02.003, 21459048.
119. Roberts JM, Hubel CA. Is oxidative stress the link in the two-stage model of pre-eclampsia?. Lancet 1999, 354(9181):788-789. 10.1016/S0140-6736(99)80002-6, 10485715.
120. Chen X, Scholl TO. Oxidative stress: changes in pregnancy and with gestational diabetes mellitus. Curr Diabetes Rep 2005, 5(4):282-288.
121. Hedderson MM, Ferrara A, Sacks DA. Gestational diabetes mellitus and lesser degrees of pregnancy hyperglycemia: association with increased risk of spontaneous preterm birth. Obstet Gynecol 2003, 102(4):850-856. 10.1016/S0029-7844(03)00661-6, 14551018.
122. Haws RA, Yakoob MY, Soomro T, Menezes EV, Darmstadt GL, Bhutta ZA. Reducing stillbirths: screening and monitoring during pregnancy and labour. BMC Pregnancy Childbirth 2009, 9(Suppl 1):S5. 10.1186/1471-2393-9-S1-S5, 2679411, 19426468.
123. Smith GC, Fretts RC. Stillbirth. Lancet 2007, 370(9600):1715-1725. 10.1016/S0140-6736(07)61723-1, 18022035.
124. Pollack RN, Yaffe H, Divon MY. Therapy for intrauterine growth restriction: current options and future directions. Clin Obstet Gynecol 1997, 40(4):824-842. 10.1097/00003081-199712000-00017, 9429797.
125. Newnham JP, Godfrey M, Walters BJ, Phillips J, Evans SF. Low dose aspirin for the treatment of fetal growth restriction: a randomized controlled trial. Aust New Zeal J Obstet Gynaecol 1995, 35(4):370-374.
126. Say L, Gulmezoglu AM, Hofmeyr GJ. Maternal nutrient supplementation for suspected impaired fetal growth. Cochrane Database Syst Rev 2003, (1):CD000148.
127. Bain E, Wilkinson D, Middleton P, Crowther CA, Dickinson H, Walker DW. Creatine for women in pregnancy for neuroprotection of the fetus. Cochrane Database Syst Rev 2013, (11):CD010846.
128. Harrison N, Larcombe-McDouall JB, Earley L, Wray S. An in vivo study of the effects of ischaemia on uterine contraction, intracellular pH and metabolites in the rat. J Physiol 1994, 476(2):349-354. 1160446, 8046648.
129. Wyss M, Braissant O, Pischel I, Salomons GS, Schulze A, Stockler S, Wallimann T. Creatine and creatine kinase in health and disease-a bright future ahead?. Sub Cell Biochem 2007, 46:309-334.